医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
血尿、微炎症状态、尿蛋白、肾间质纤维化、脉压小、糖代谢紊乱、顽固性高血压、代谢性酸中毒
Renoparenchymal hypertension is secondary hypertension due to intrinsic renal parenchymal disease (glomerulonephritis, chronic kidney disease, polycystic kidney), common and often severe. Treatment: strict BP control (target <130/80); renal-protective ACE inhibitor/ARB; low-salt diet; treat underlying renal disease; dialysis/transplant for end-stage kidney disease; monitor electrolytes and renal function.
Hypertension; underlying renal disease; edema/proteinuria; CKD progression
Renal parenchymal disease causes sodium retention and RAAS activation, raising BP.
Strict BP control; ACEi/ARB (renal protection); low salt; treat renal disease; dialysis if ESKD
Screen BP/renal function in renal disease; low salt.
It is recommended to visit the Nephrology department; an appointment can be booked on this platform before the visit.
Warm reminder: The above information is for health science reference only and cannot replace professional medical diagnosis. If you have related symptoms, please seek medical attention at a regular hospital promptly.
|
